Parallax Volatility Advisers, L.P. Novo Cure LTD Put Options Transaction History

Parallax Volatility Advisers, L.P.

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $119,091 - $168,846	10,700 New	10,700 $159,000
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $1.33 Million - $2.72 Million	-33,000 Reduced 74.66%	11,200 $464,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $846,600 - $1.78 Million	-15,000 Reduced 25.34%	44,200 $2.66 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $3.79 Million - $5.05 Million	59,200 New	59,200 $4.34 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $33,960 - $53,940	-600 Reduced 60.0%	400 $28,000

Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $142,652 - $231,781	-1,900 Reduced 65.52%	1,000 $75,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $10.4 Million - $17.4 Million	-89,500 Reduced 96.86%	2,900 $337,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $10.4 Million - $16.1 Million	92,400 New	92,400 $16 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $13.2 Million - $20.5 Million	-117,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $1.99 Million - $3.82 Million	34,300 Added 41.23%	117,500 $13.1 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $5.06 Million - $6.59 Million	-88,500 Reduced 51.54%	83,200 $4.94 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $9.8 Million - $16.4 Million	171,700 New	171,700 $11.6 Million
Q3 2018 Nov 14, 2018	SELL	$32.0 - $52.4 $1.6 Million - $2.62 Million	-50,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $992,500 - $1.6 Million	50,000 New	50,000 $1.57 Million

277

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.